Search - tctmd.com

Displaying 221 - 240 of 640

Sort: Relevancy | Date

Presentation ISET 2019

Drug-Coated Therapy for ISR: Review of Options and Data

Presenter: Brian DeRubertis

January 30, 2019

Presentation CHIP Florida 2019

In-stent Restenosis: Assess and Treat on the Basis of Cause

Presenter: Jeffrey W. Moses

January 25, 2019

Presentation

Frequency of TVR With DCB vs Second-Generation DES for Coronary In-Stent Restenosis

January 15, 2019

News Daily News

Slight Advantage for DES Over DCB for In-Stent Restenosis: Updated Meta-analysis

Todd Neale

January 15, 2019

News Conference News AHA 2018

New-Generation DES Better Than Older Stents Over 10 Years, Regardless of Polymer Type

Todd Neale

November 12, 2018

News Daily News

Debate Over BMS vs DES in High-Bleeding-Risk Scenarios Gets Fresh Fuel in Meta-analysis

Yael L. Maxwell

November 05, 2018

Presentation TCT Abstracts Posters 2018

Comparison of the Outcomes with or without Excimer Laser Coronary Angioplasty for the Treatment of Coronary In-Stent Restenosis using Paclitaxel-Coated Balloon

Presenter: Motoyoshi Maenaka

September 25, 2018

Presentation TCT Abstracts Posters 2018

Comparison of the Outcomes with or without Excimer Laser Coronary Angioplasty for the Treatment of Coronary In-Stent Restenosis using Paclitaxel-Coated Balloon

Presenter: Motoyoshi Maenaka

September 25, 2018

Presentation TCT 2018

Case #12: A Case of In-Stent Restenosis Due to a Markedly Under-expanded Stent in a Severely Calcified Lesion

Presenter: Philippe Genereux, Ajay J. Kirtane, Alaide Chieffo, Carlo Di Mario, Stefan Harb, Richard A. Schatz, Sigmund Silber

September 24, 2018

Presentation TCT 2018

Case #10: A Case in Which Intravascular Imaging Demonstrated a Surprising Cause and Guided Treatment of In-stent Restenosis

Presenter: David Erlinge, Gary S. Mintz, Martin W. Bergmann, Marc D. Feldman, Margaret B. McEntegart, Yasunori Ueda, Carlo Zivelonghi, Robert-Jan van Geuns

September 24, 2018

Presentation TCT 2018

DCB for Coronary Artery Disease: In-Stent Restenosis, NSTEMI, and Small Vessels

Presenter: Juan F. Granada, Bruno Scheller

September 23, 2018

Presentation TCT 2018

RESTORE ISR China: A Randomized Trial of Two Different Drug-Coated Balloons for Treatment of In-Stent Restenosis After Drug-Eluting Stent Implantation

Presenter: Fernando Alfonso, Juan F. Granada, YunDai Chen

September 23, 2018

Presentation TCT 2018

TCT-39: Functional Assessment of In-stent Restenosis With Quantitative Flow Ratio (QFR). A Comparison With De Novo Coronary Stenoses

Presenter: Javier Escaned, Tim P. Van de Hoef, Catherine Liontou

September 21, 2018

Presentation TCT 2018

Sirolimus Angioplasty Balloon for In-Stent Restenosis (SABRE) Trial: 3-Year Clinical Follow-Up (Caliber)

Presenter: Juan F. Granada

September 21, 2018

News Conference News ESC 2018

BASKET-SMALL 2: Drug-Coated Balloon Fares Well Against DES for De Novo Small-Vessel Disease

Todd Neale

August 28, 2018

Podcast TCTMD Talking Points

DARE: A Randomized Trial of a Drug-Eluting Balloon vs a Metallic DES in Patients With Coronary Artery In-Stent Restenosis

June 20, 2018

News Industry News

Medtronic Receives FDA Approval for 200mm & 250mm IN.PACT(TM) Admiral(TM) Drug Coated Balloons

June 18, 2018

News Conference News EuroPCR 2018

DES Slightly Edge Out DCBs in Treatment of In-Stent Restenosis: Meta-analysis

Caitlin E. Cox

May 30, 2018

News Conference News EuroPCR 2018

DCBs for CAD in Certain Patients With Large Vessel De Novo Disease? DEBUT Says Yes

Caitlin E. Cox

May 25, 2018

News Industry News

Medtronic IN.PACT(TM) Admiral(TM) Drug Coated Balloon Receives FDA Approval to Treat Long SFA Lesions

April 24, 2018

Advertisement

Drug-Coated Therapy for ISR: Review of Options and Data

In-stent Restenosis: Assess and Treat on the Basis of Cause

Frequency of TVR With DCB vs Second-Generation DES for Coronary In-Stent Restenosis

Slight Advantage for DES Over DCB for In-Stent Restenosis: Updated Meta-analysis

New-Generation DES Better Than Older Stents Over 10 Years, Regardless of Polymer Type

Debate Over BMS vs DES in High-Bleeding-Risk Scenarios Gets Fresh Fuel in Meta-analysis

Comparison of the Outcomes with or without Excimer Laser Coronary Angioplasty for the Treatment of Coronary In-Stent Restenosis using Paclitaxel-Coated Balloon

Comparison of the Outcomes with or without Excimer Laser Coronary Angioplasty for the Treatment of Coronary In-Stent Restenosis using Paclitaxel-Coated Balloon

Case #12: A Case of In-Stent Restenosis Due to a Markedly Under-expanded Stent in a Severely Calcified Lesion

Case #10: A Case in Which Intravascular Imaging Demonstrated a Surprising Cause and Guided Treatment of In-stent Restenosis

DCB for Coronary Artery Disease: In-Stent Restenosis, NSTEMI, and Small Vessels

RESTORE ISR China: A Randomized Trial of Two Different Drug-Coated Balloons for Treatment of In-Stent Restenosis After Drug-Eluting Stent Implantation

TCT-39: Functional Assessment of In-stent Restenosis With Quantitative Flow Ratio (QFR). A Comparison With De Novo Coronary Stenoses

Sirolimus Angioplasty Balloon for In-Stent Restenosis (SABRE) Trial: 3-Year Clinical Follow-Up (Caliber)

BASKET-SMALL 2: Drug-Coated Balloon Fares Well Against DES for De Novo Small-Vessel Disease

DARE: A Randomized Trial of a Drug-Eluting Balloon vs a Metallic DES in Patients With Coronary Artery In-Stent Restenosis

Medtronic Receives FDA Approval for 200mm & 250mm IN.PACT(TM) Admiral(TM) Drug Coated Balloons

DES Slightly Edge Out DCBs in Treatment of In-Stent Restenosis: Meta-analysis

DCBs for CAD in Certain Patients With Large Vessel De Novo Disease? DEBUT Says Yes

Medtronic IN.PACT(TM) Admiral(TM) Drug Coated Balloon Receives FDA Approval to Treat Long SFA Lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content